PAUL MODAFFERI: Open Payments
NPI 1760880082 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,443 in 106 payments from 21 companies in 2025. Trend: 2023 $2,642 · 2024 $2,726 · 2025 $2,443
Food & beverage: $2,443
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $501 |
| PFIZER INC. | 22 | $415 |
| Novo Nordisk Inc | 11 | $269 |
| AstraZeneca Pharmaceuticals LP | 8 | $256 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $140 |
| ABBVIE INC. | 11 | $138 |
| Phathom Pharmaceuticals, Inc. | 1 | $123 |
| Astellas Pharma US Inc | 5 | $97 |
| UCB, Inc. | 3 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $79 |
Products named: EVENITY, NURTEC ODT, BREZTRI, Ozempic, Kerendia, VOQUEZNA, Veozah, Wegovy.
Industry payments across FL — which companies pay providers there.
